Orphan Drug Designation Granted to Rezafungin in EU for the Treatment of Invasive Candidiasis admin Wed, 01/27/2021 - 16:35
source https://www.pharmatutor.org/pharma-news/2021/orphan-drug-designation-granted-to-rezafungin-in-eu-for-the-treatment-of-invasive-candidiasis
Subscribe to:
Post Comments (Atom)
-
The National Institutes of Health announced a new initiative aimed at speeding innovation, development and commercialization of COVID-19...
-
Results from a clinical trial published in 2011 confirmed the benefit of using Avastin over laser therapy for treating the most severe c...
-
National Institute for Research in Reproductive Health (NIRRH), formerly known as Institute for Research in Reproduction is a premier res...
No comments:
Post a Comment